Myriad Genetics | MYGN - Pre Tax Profit


Myriad Genetics reported $4.6M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 408M 44M Mar/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Bio-Rad Laboratories USD 542.1M 1.23B Jun/2026
Bruker USD 117M 95.1M Jun/2026
Danaher USD 1.08B 157M Jun/2026
Illumina USD 260M 103M Jun/2026
J&J USD 8.66B 839M Jun/2026
Mettler Toledo International USD 209.66M 119.42M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 14.15M 12.38M Jun/2026
Revvity USD 187.24M 137.25M Jun/2026
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Veracyte USD 26.52M 3.45M Jun/2026
Waters USD 356M 444M Jun/2026